CLYM — Climb Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Climb Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	136	124	107	151	101
Net Total Receivables	—	—	—	1.12	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	148	134	110	155	106
Net Property, Plant And Equipment	—	0.471	0.199	0.49	0.793
Other Long Term Assets
Total Assets	173	135	110	217	168
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	6.04	6.1	2.83	4.93	6.98
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.04	6.28	2.87	5.31	7.27
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	167	129	108	212	160
Total Liabilities & Shareholders' Equity	173	135	110	217	168
Total Common Shares Outstanding
Total Preferred Shares Outstanding